IRIS
Berti, Alvise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.239
NA - Nord America 2.556
EU - Europa 1.684
SA - Sud America 737
AF - Africa 93
OC - Oceania 20
Totale 8.329
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.467
SG - Singapore 1.208
CN - Cina 628
VN - Vietnam 598
IT - Italia 590
BR - Brasile 575
RU - Federazione Russa 239
HK - Hong Kong 231
FR - Francia 141
KR - Corea 131
DE - Germania 119
GB - Regno Unito 119
LV - Lettonia 119
FI - Finlandia 108
IN - India 104
NL - Olanda 73
ID - Indonesia 72
AR - Argentina 58
EC - Ecuador 45
CA - Canada 41
JP - Giappone 37
BD - Bangladesh 36
AT - Austria 33
ES - Italia 33
MX - Messico 33
ZA - Sudafrica 26
IQ - Iraq 24
CO - Colombia 23
SE - Svezia 23
TR - Turchia 20
AU - Australia 17
MA - Marocco 17
UA - Ucraina 17
IR - Iran 16
PL - Polonia 16
PK - Pakistan 15
SA - Arabia Saudita 15
TW - Taiwan 13
EG - Egitto 12
IE - Irlanda 12
MY - Malesia 12
PH - Filippine 12
VE - Venezuela 12
CL - Cile 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
PS - Palestinian Territory 8
AZ - Azerbaigian 7
DZ - Algeria 7
KE - Kenya 7
PY - Paraguay 7
JO - Giordania 6
NP - Nepal 6
UZ - Uzbekistan 6
BE - Belgio 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LT - Lituania 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
LB - Libano 4
PE - Perù 4
LK - Sri Lanka 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
TH - Thailandia 3
AD - Andorra 2
AL - Albania 2
BB - Barbados 2
CR - Costa Rica 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 8.325
Salva come PNG Salva come JPEG
Città #
Singapore 790
San Jose 437
Ashburn 399
Santa Clara 263
Trento 254
Dallas 228
Hong Kong 207
Columbus 188
Ho Chi Minh City 181
Hanoi 130
Moscow 126
Seoul 125
Riga 119
Hefei 103
Lauterbourg 100
Los Angeles 92
Council Bluffs 76
Beijing 74
Helsinki 72
New York 57
The Dalles 53
Buffalo 50
São Paulo 48
Rome 47
Redondo Beach 39
Milan 38
Jakarta 36
Da Nang 32
Chicago 29
Rio de Janeiro 29
Haiphong 27
Lappeenranta 26
Orem 26
Tokyo 24
Washington 23
Munich 22
Nuremberg 22
Boardman 20
Can Tho 20
Frankfurt am Main 19
London 19
Chennai 18
Stockholm 18
Montreal 17
Shanghai 17
Quito 16
Biên Hòa 15
Bắc Ninh 15
Castello Molina di Fiemme 15
Groningen 15
Guangzhou 15
Manchester 15
Vienna 15
Warsaw 15
Guayaquil 13
Hải Dương 13
Johannesburg 13
Gurugram 12
Mexico City 12
Ogden 12
Thái Bình 12
Amsterdam 11
Falkenstein 11
Kilburn 11
Paris 11
Poplar 11
Tampa 11
Baghdad 10
Hyderabad 10
Pamplona 10
Salt Lake City 10
Turku 10
Wilmington 10
Belo Horizonte 9
Brasília 9
Dublin 9
Mumbai 9
Naples 9
Ninh Bình 9
Porto Alegre 9
Salvador 9
Turin 9
Atlanta 8
Boston 8
Cape Town 8
Istanbul 8
Ramallah 8
San Francisco 8
Toronto 8
Baku 7
Bogotá 7
Bologna 7
Brooklyn 7
Buenos Aires 7
Cairo 7
Campinas 7
Changsha 7
Elk Grove Village 7
Fort Worth 7
Phoenix 7
Totale 5.303
Salva come PNG Salva come JPEG
Nome #
Autoreactive B Cells in ANCA-Associated Vasculitis 192
Small airway dysfunction and impulse oscillometry in adult patients with asthma: recent findings 169
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 156
Impulse oscillometry for the evaluation and management of pediatric asthma 129
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 126
A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis 120
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 117
Severe asthma: One disease and multiple definitions 112
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study 111
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 106
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 104
Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management 104
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 103
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 100
Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control 100
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 99
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 96
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls 96
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 95
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 94
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 92
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 92
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis 91
Oscillometry-defined small airways dysfunction as a treatable trait in asthma 89
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 88
Asthma and COVID-19: a dangerous liaison? 87
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 86
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 86
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions 86
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis 85
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes 85
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 84
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 83
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab 83
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis 83
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series 83
Diagnosing and treating ANCA-Associated vasculitis: An updated review for clinical practice 82
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 81
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 80
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab 80
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil 78
Allergic rhinitis and COVID-19: friends or foes? 77
Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease 76
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. 76
Authors' response 76
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 76
Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely 75
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 75
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 74
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 72
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study 70
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis 70
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report 69
Correction to: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan (Drugs, (2024), 84, 6, (661-684), 10.1007/s40265-024-02037-0) 68
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 68
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 68
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 67
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis 67
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis 67
Small Airways: The “Silent Zone” of 2021 GINA Report? 65
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study 65
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 65
Tocilizumab in patients with multisystem Erdheim-Chester disease 63
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. 63
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature 63
Efficacy and safety of biological agents in adult-onset Still's disease 62
Cardiovascular manifestations of Erdheim-Chester disease 62
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 62
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 62
Prevalence and features of IOS-defined small airway disease across asthma severities 62
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity 61
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 61
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies 59
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 59
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity 59
Drug induced exfoliative dermatitis: state of the art. 59
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma 57
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis 56
Remission maintenance in ANCA-associated vasculitis: does one size fit all? 56
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: A systematic literature review 56
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 56
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 56
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 55
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease 55
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates 55
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease 55
Targeting the interleukin-5 pathway in EGPA: Evidence, uncertainties and opportunities 54
Juxta-vertebral lesions in granulomatosis with polyangiitis 53
Erdheim-Chester disease 53
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 53
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis 53
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia 53
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 52
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides 52
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia 52
Small-airway dysfunction in paediatric asthma 52
Treatments for giant cell arteritis: Metaanalysis and assessment of estimates reliability using the fragility index 52
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media 51
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 51
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 50
Totale 7.744
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 137
Totale 37.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 2 9 3 2 7 2 5 3 4
2022/2023328 4 0 0 1 0 0 0 0 0 123 107 93
2023/2024322 1 1 32 13 53 83 27 12 3 27 19 51
2024/20252.850 64 22 307 499 157 303 37 97 221 298 245 600
2025/20265.173 282 201 705 1.036 570 324 1.013 145 513 384 0 0
Totale 8.710